Lymphoma: By: Angel R. Aggabao

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 11

LYMPHOMA

By: Angel R. Aggabao


• is cancer that begins in infection-fighting
cells of the immune system, called
lymphocytes. These cells are in the lymph
nodes, spleen, thymus, bone marrow, and
other parts of the body.

Lymphoma
• For all lymphomas combined, prevalence ranged
from 48.0 (95% CI 45.8–50.3) per 100 000
Incidence population within 3 years of diagnosis, through to
72.5 (95% CI 69.7–75.3) per 100 000 within 5 years
and 123.7 (95% CI 120.0–127.4) within 10 years.
Pathophysiology
• Enlarged lymph nodes
• Chills
• Weight loss
• Fatigue (feeling very tired)

Sign & • Swollen abdomen (belly)


• Feeling full after only a small amount of food
Symptoms • Chest pain or pressure
• Shortness of breath or cough
• Severe or frequent infections
• Easy bruising or bleeding
• Age. People between the ages of 15 and 40 and people older
than 55 are more likely to develop Hodgkin lymphoma.
• Gender. In general, men are slightly more likely to develop
Hodgkin lymphoma than women, although the nodular sclerosis
subtype is more common in women.
• Family history. Brothers and sisters of people with Hodgkin
lymphoma have a higher chance of developing the disease,
although the increase in risk is small.

Risk Factors • Virus exposure. The Epstein-Barr virus (EBV) causes infectious


mononucleosis, often called "mono." Nearly all adult Americans
and many others around the world have an EBV infection.
About 20% to 25% of people with cHL in the United States have
lymphoma cells that test positive for EBV. Although a person’s
immune system response to an infection with EBV may be
important in the development of Hodgkin lymphoma, doctors
still do not understand why, when so many people have been
infected with EBV, relatively very few people ever develop
Hodgkin lymphoma. People with HIV also have a higher risk of
developing Hodgkin lymphoma, particularly lymphocyte-
depleted Hodgkin lymphoma.
Tumor Marker

• CD20
• Cancer type: Non-Hodgkin lymphoma
What's analyzed: Blood
How used: To determine whether treatment with a targeted therapy is appropriate
• Lactate dehydrogenase
• Cancer types: Germ cell tumors, lymphoma, leukemia, melanoma, and neuroblastoma
What's analyzed: Blood
How used: To assess stage, prognosis, and response to treatment
• Programmed death ligand 1 (PD-L1)
• Cancer types: Non-small cell lung cancer, liver cancer, stomach cancer, gastroesophageal junction
 cancer, classical Hodgkin lymphoma, and other aggressive lymphoma subtypes
What's analyzed: Tumor
How used: To determine whether treatment with a particular type of targeted therapy is appropriate
• T-cell receptor gene rearrangement
• Cancer type: T-cell lymphoma
What's analyzed: Bone marrow, tissue, body fluid, blood
How used: To help in diagnosis; sometimes to detect and evaluate residual disease
Diagnostic Test

• bone marrow aspiration and biopsy, lumbar puncture, chest x-ray, body
CT, PET, bone scan, body MRI or abdominal ultrasound may be used to
look for enlarged lymph nodes throughout the body
and determine whether the lymphoma has spread.
Medical Intervention

• Non-Surgical

Active surveillance. Some forms of lymphoma are very slow


growing. ...
• Chemotherapy. Chemotherapy uses drugs to destroy fast-growing
cells, such as cancer cells. ...
• Radiation therapy. ...
Medical Intervention

• Surgical

You might also like